Emergent BioSolutions Ownership | Who Owns Emergent BioSolutions?

Overview Forecast RevenueFinancials Chart Transcripts

Emergent BioSolutions Ownership Summary

Emergent BioSolutions is owned by 65.27% institutional investors, 2.15% insiders, and 32.58% retail investors. Blackrock is the largest institutional shareholder, holding 7.36% of EBS shares. Avantis US Small Cap Value ETF is the top mutual fund, with 3.56% of its assets in Emergent BioSolutions shares.

EBS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Emergent BioSolutions	65.27%	2.15%	32.58%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Specialty & Generic Drug Manufacturers Stocks	26.69%	10.91%	62.39%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	3.84M	7.36%	$26.18M
Vanguard group	3.20M	6.03%	$30.60M
American century companies	2.14M	4.03%	$20.44M
State street	1.96M	3.70%	$18.77M
Blackrock funding, inc. /de	1.92M	3.62%	$18.38M
Invesco	1.54M	2.90%	$14.72M
Millennium management	1.48M	2.79%	$14.17M
Marshall wace, llp	1.33M	2.50%	$12.70M
Charles schwab investment management	1.29M	2.43%	$12.33M
Morgan stanley	1.24M	2.38%	$8.47M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Values first advisors	376.69K	1.98%	$3.60M
Oak hill advisors lp	1.11M	1.96%	$10.64M
Kent lake capital	300.00K	0.92%	$2.05M
Morse asset management	158.82K	0.35%	$1.52M
Prescott group capital management	210.00K	0.27%	$2.01M
Palisade capital management, lp	938.73K	0.24%	$8.97M
Point72 asia (singapore) pte.	42.71K	0.11%	$408.32K
Whitebox advisors	500.00K	0.10%	$3.41M
Seacrest wealth management	93.70K	0.09%	$895.77K
Hilltop	154.38K	0.09%	$1.48M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	1.48M	0.01%	671.95K
Invesco	1.54M	0.00%	639.00K
Goldman sachs group	969.07K	0.00%	521.22K
Whitebox advisors	500.00K	0.10%	500.00K
Qube research	815.79K	0.01%	477.85K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock	3.84M	0.00%	-3.22M
Avidity partners management lp	-	-	-1.91M
Marshall wace, llp	1.33M	0.02%	-1.17M
Charles schwab investment management	1.29M	0.00%	-934.50K
Aqr capital management	460.31K	0.00%	-591.39K

New Positions

Holder	Shares	% Assets	Change	Value
Whitebox advisors	500.00K	0.10%	500.00K	$3.41M
Kent lake capital	300.00K	0.92%	300.00K	$2.05M
Man group	176.78K	0.00%	176.78K	$1.69M
Schonfeld strategic advisors	145.91K	0.01%	145.91K	$1.39M
Wolverine asset management	136.33K	0.01%	136.33K	$1.30M

Sold Out

Holder	Change
Federation des caisses desjardins du quebec	-4.00
Strengthening families & communities	-9.00
Financial gravity asset management	-9.00
Nelson, van denburg & campbell wealth management group	-10.00
Nemes rush group	-42.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	160	6.67%	34,658,921	9.38%	65	1.83%	78	21.88%	38	-24.00%
Sep 30, 2024	149	5.67%	31,651,679	4.07%	59	1.78%	64	-21.95%	50	42.86%
Jun 30, 2024	139	10.32%	30,408,059	-15.80%	58	1.22%	80	53.85%	35	-22.22%
Mar 31, 2024	126	-9.35%	36,115,932	-11.70%	69	1.08%	52	-14.75%	45	-2.17%
Dec 31, 2023	139	-16.27%	40,903,645	-0.92%	79	1.26%	61	-15.28%	46	-16.36%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Avantis US Small Cap Value ETF	1.94M	3.56%	910.00
Vanguard US Total Market Shares ETF	1.64M	3.01%	-
Vanguard Total Stock Mkt Idx Inv	1.57M	2.89%	-
SPDR® S&P Biotech ETF	1.36M	2.50%	-14.58K
Invesco FTSE RAFI US 1500 Small-Mid ETF	917.91K	1.69%	-
Vanguard Institutional Extnd Mkt Idx Tr	827.41K	1.52%	1.25K
Invesco RAFI US 1500 Small-Mid ETF	747.96K	1.38%	-
Palisade Small Cap Core Equity	592.34K	1.09%	171.60K
Invesco Dorsey Wright SmallCap Momt ETF	485.58K	0.89%	-3.47K
Vanguard Strategic Equity Inv	465.32K	0.86%	-117.65K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 12, 2025	Fowler Neal Franklin	-	Sell	$204.05K
Mar 12, 2025	Zoon Kathryn C	-	Sell	$57.30K
Nov 12, 2024	DeGolyer Donald W	-	Sell	$272.75K
Nov 11, 2024	White Marvin L	-	Sell	$171.02K
Jun 04, 2024	Zoon Kathryn C	-	Sell	$61.10K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	2
2024 Q4	-	2
2024 Q3	-	-
2024 Q2	-	3
2024 Q1	-	-

EBS Ownership FAQ

Who Owns Emergent BioSolutions?

Emergent BioSolutions shareholders are primarily institutional investors at 65.27%, followed by 2.15% insiders and 32.58% retail investors. The average institutional ownership in Emergent BioSolutions's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Emergent BioSolutions exceeds.

Who owns the most shares of Emergent BioSolutions?

Emergent BioSolutions’s largest shareholders are Blackrock (3.84M shares, 7.36%), Vanguard group (3.2M shares, 6.03%), and American century companies (2.14M shares, 4.03%). Together, they hold 17.41% of Emergent BioSolutions’s total shares outstanding.

Does Blackrock own Emergent BioSolutions?

Yes, BlackRock owns 7.36% of Emergent BioSolutions, totaling 3.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.18M$. In the last quarter, BlackRock decreased its holdings by -3.221M shares, a -45.62% change.

Who is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested?

Values first advisors is Emergent BioSolutions’s biggest shareholder by percentage of total assets invested, with 1.98% of its assets in 376.69K Emergent BioSolutions shares, valued at 3.6M$.

Who is the top mutual fund holder of Emergent BioSolutions shares?

Avantis US Small Cap Value ETF is the top mutual fund holder of Emergent BioSolutions shares, with 3.56% of its total shares outstanding invested in 1.94M Emergent BioSolutions shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools